Homology Medicines Price History

FIXXDelisted Stock  USD 1.09  0.06  5.83%   
If you're considering investing in Homology Stock, it is important to understand the factors that can impact its price. As of today, the current price of Homology Medicines stands at 1.09, as last reported on the 26th of November, with the highest price reaching 1.10 and the lowest price hitting 1.02 during the day. We have found twenty-nine technical indicators for Homology Medicines, which you can use to evaluate the volatility of the firm. Please check out Homology Medicines' Market Risk Adjusted Performance of 2.34, risk adjusted performance of 0.0398, and Downside Deviation of 4.11 to validate if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Homology Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
FIXX
Based on monthly moving average Homology Medicines is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Homology Medicines by adding Homology Medicines to a well-diversified portfolio.

Homology Medicines Stock Price History Chart

There are several ways to analyze Homology Stock price data. The simplest method is using a basic Homology candlestick price chart, which shows Homology Medicines price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Homology Stock Price History Data

The price series of Homology Medicines for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 has a statistical range of 0.29 with a coefficient of variation of 7.35. Under current investment horizon, the daily prices are spread out with arithmetic mean of 0.98. The median price for the last 90 days is 0.99. The company completed 1:18 stock split on 25th of March 2024.
OpenHighLowCloseVolume
11/26/2024
 1.03  1.10  1.02  1.09 
07/24/2023 1.03  1.10  1.02  1.09  299,554 
07/21/2023 1.10  1.10  1.03  1.04  113,661 
07/20/2023 0.99  1.12  0.97  1.09  209,123 
07/19/2023 0.96  1.00  0.96  1.00  256,022 
07/18/2023 0.97  0.98  0.94  0.97  192,575 
07/17/2023 0.97  0.97  0.91  0.97  167,259 
07/14/2023 0.98  0.98  0.95  0.95  68,940 
07/13/2023 0.92  0.98  0.92  0.98  198,263 
07/12/2023 0.93  0.94  0.88  0.92  109,655 
07/11/2023 0.89  0.94  0.88  0.92  163,815 
07/10/2023 0.85  0.90  0.84  0.89  139,216 
07/07/2023 0.82  0.86  0.82  0.85  161,257 
07/06/2023 0.85  0.88  0.84  0.84  236,384 
07/05/2023 0.82  0.88  0.81  0.88  190,404 
07/03/2023 0.84  0.88  0.83  0.85  134,037 
06/30/2023 0.86  0.93  0.86  0.89  174,320 
06/29/2023 0.82  0.90  0.81  0.87  171,301 
06/28/2023 0.83  0.84  0.80  0.83  84,115 
06/27/2023 0.86  0.86  0.80  0.84  208,030 
06/26/2023 0.87  0.90  0.81  0.90  239,056 
06/23/2023 0.93  0.94  0.87  0.89  341,802 
06/22/2023 0.92  0.95  0.89  0.93  224,923 
06/21/2023 0.98  0.98  0.91  0.93  421,414 
06/20/2023 1.06  1.09  1.04  1.05  130,201 
06/16/2023 1.02  1.08  1.02  1.08  161,249 
06/15/2023 1.01  1.05  0.99  1.00  91,227 
06/14/2023 1.05  1.10  1.03  1.03  91,014 
06/13/2023 1.07  1.12  1.02  1.04  85,044 
06/12/2023 1.14  1.14  1.09  1.12  77,300 
06/09/2023 1.09  1.14  1.09  1.12  104,170 
06/08/2023 1.10  1.10  1.07  1.10  37,370 
06/07/2023 1.07  1.11  1.03  1.10  90,061 
06/06/2023 0.99  1.07  0.98  1.04  96,452 
06/05/2023 0.97  1.01  0.96  0.99  43,600 
06/02/2023 1.00  1.03  0.98  0.99  55,700 
06/01/2023 1.04  1.04  0.95  1.00  31,475 
05/31/2023 1.04  1.04  0.95  0.98  78,633 
05/30/2023 0.99  1.04  0.97  0.97  89,313 
05/26/2023 1.02  1.02  0.97  1.02  114,285 
05/25/2023 1.07  1.08  1.00  1.01  103,332 
05/24/2023 1.08  1.08  1.03  1.07  86,520 
05/23/2023 1.03  1.09  1.00  1.08  169,043 
05/22/2023 1.07  1.07  1.00  1.04  84,720 
05/19/2023 1.05  1.07  1.03  1.06  67,065 
05/18/2023 1.01  1.06  1.01  1.04  42,200 
05/17/2023 1.05  1.07  1.00  1.04  111,762 
05/16/2023 0.99  1.07  0.99  1.05  80,799 
05/15/2023 0.98  1.04  0.98  1.02  73,857 
05/12/2023 0.99  1.02  0.96  0.98  135,670 
05/11/2023 0.98  1.01  0.95  1.00  59,007 
05/10/2023 1.02  1.02  0.97  0.98  92,953 
05/09/2023 1.03  1.03  0.98  1.02  65,545 
05/08/2023 1.00  1.01  0.96  1.01  55,503 
05/05/2023 1.00  1.00  0.98  1.00  139,254 
05/04/2023 1.00  1.00  0.96  0.98  50,648 
05/03/2023 0.90  1.00  0.90  0.97  83,044 
05/02/2023 0.93  0.95  0.90  0.92  51,721 
05/01/2023 0.97  0.98  0.91  0.94  129,682 
04/28/2023 0.93  0.97  0.93  0.95  66,133 
04/27/2023 0.91  0.98  0.91  0.95  63,117 

About Homology Medicines Stock history

Homology Medicines investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Homology is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Homology Medicines will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Homology Medicines stock prices may prove useful in developing a viable investing in Homology Medicines
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts. Homology Medicines operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 224 people.

Homology Medicines Stock Technical Analysis

Homology Medicines technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Homology Medicines technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Homology Medicines trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Funds Screener Now

   

Funds Screener

Find actively-traded funds from around the world traded on over 30 global exchanges
All  Next Launch Module

Homology Medicines Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Homology Medicines' price direction in advance. Along with the technical and fundamental analysis of Homology Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Homology to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Consideration for investing in Homology Stock

If you are still planning to invest in Homology Medicines check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Homology Medicines' history and understand the potential risks before investing.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Global Correlations
Find global opportunities by holding instruments from different markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine